Repligen Corp
RGENNasdaqCIK 730272HealthcareFiscal year ends Dec 31
Reports and events: 292 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:01 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-068562 |
| 2026-10-3006:04 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-068382 |
| 2026-10-2707:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067405 |
| 2026-10-0609:14 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-415015 |
| 2026-09-1516:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-062043 |
| 2026-09-0817:26 ET | 8-K | 8.01 Other events | 0001193125-26-385380 |
| 2026-07-2916:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-323773 |
| 2026-07-2807:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318853 |
| 2026-07-2208:56 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-311402 |
| 2026-05-1508:09 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-225380 |
| 2026-05-0616:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-208954 |
| 2026-05-0507:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205011 |
| 2026-04-0216:13 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001193125-26-140115 |
| 2026-02-2616:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076528 |
| 2026-02-2407:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-065246 |
| 2026-01-0607:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-003467 |
| 2025-11-0416:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264666 |
| 2025-10-2807:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-252385 |
| 2025-09-0208:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-193481 |
| 2025-08-0716:46 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105166 |
| 2025-07-2907:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099389 |
| 2025-05-1516:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-072664 |
| 2025-04-2916:17 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-060156 |
| 2025-04-2907:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-059569 |
| 2025-04-0416:15 ET | DEF 14A | Proxy statementPeriod 2025-04-03 | 0000950170-25-051141 |
| 2025-03-1419:14 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038999 |
| 2025-02-2007:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023742 |
| 2024-11-1812:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-127846 |
| 2024-11-1812:08 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-06-30 | 0000950170-24-127845 |
| 2024-11-1812:07 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0000950170-24-127844 |
| 2024-11-1812:06 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-127842 |
| 2024-11-1812:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-09-30 | 0000950170-24-127841 |
| 2024-11-1812:03 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0000950170-24-127839 |
| 2024-11-1812:02 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0000950170-24-127837 |
| 2024-11-1207:44 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255167 |
| 2024-09-1816:21 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-221406 |
| 2024-07-3017:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-087981 |
| 2024-07-3007:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-188277 |
| 2024-07-1516:05 ET | 8-K | 8.01 Other events | 0001193125-24-179061 |
| 2024-06-1417:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-161728 |
| 2024-06-1307:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-160292 |
| 2024-05-1708:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-141217 |
| 2024-05-0116:22 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-051310 |
| 2024-05-0107:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-126349 |
| 2024-04-0116:17 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0001193125-24-083397 |
| 2024-03-1907:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-070768 |
| 2024-02-2216:26 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-018809 |
| 2024-02-2107:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-040727 |
| 2023-12-1516:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-296692 |
| 2023-12-0707:39 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-290319 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:08 ET. Listed shows no prices and gives no investment advice.